Manufacturing capacity in Canada is one of the biggest concerns, and that was highlighted very early on in the pandemic, and before. Part of the funds that the government announced early on in the pandemic were to be provided to the National Research Council, NRC, to upgrade its facility in Montreal. This will permit it to do what's called a GMP, or a good manufacturing process, when manufacturing the vaccine. Based on that, my understanding is that it will be able to supply the needs with CanSino's vaccine.
Now obviously that's not the only vaccine that's being developed. My understanding is that each manufacturer, when it's doing studies and getting supported, in order to get support from the Canadian government, has to demonstrate what its plan is for manufacturing. Whether they are proposed vaccines from Medicago or VIDO-InterVac, all have to look at the manufacturing capacity.
I think manufacturing capacity will be an issue. Obviously, the larger multinationals, such as Sanofi Pasteur, which Dr. Neame mentioned, certainly have the manufacturing capacity.